BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2005
View Archived Issues
Novel CRTH2 receptor antagonist with acceptable PK profile
Read More
TK inhibitors fail to stop tumor growth in vivo
Read More
Novel H3 receptor antagonist improves memory retention, learning and attention in rats
Read More
Zoledronic acid reported more effective than risedronate in Paget's disease of the bone
Read More
Update on the benefits of insulin glulisine in diabetes
Read More
Daiichi Suntory Pharma acquired by Daiichi Pharmaceuticals
Read More
PharmaMar initiates Aplidin combination clinical program
Read More
Aridol lung function test enters phase II clinical evaluation for COPD
Read More
Altadyne acquires Stem Cell Therapy International Corp.
Read More
Cryptome and University of Virginia expand vascular leak alliance
Read More
Durect completes phase II trial of SABER pain relief depot
Read More
KB-2115 shows promise in phase Ia trials
Read More
Promising phase II data prompts continuation of talabostat combination trial
Read More
Viventia Biotech receives FDA approval to begin phase II Proxinium trials
Read More
StemCells files IND amendment to begin stem cell therapy in Batten disease
Read More
JTT-010: A novel PKCbeta inhibitor with therapeutic benefits in diabetic complications
Read More
Intercell advances JEV vaccine to phase III
Read More
Photofrin photodynamic therapy finds utility in Barrett's esophagus, esophageal cancer
Read More
ViaCell suspends phase I trial of CB-001
Read More
Marketing suspension of Hexavac recommended by the EMEA
Read More
Tarceva receives E.U. approval for lung cancer
Read More
Update on the antidiabetic effects of muraglitazar
Read More
Ticilimumab shows a favorable safety profile in advanced melanoma patients
Read More
Update on the therapeutic benefits of rotigotine in Parkinson's disease and RLS
Read More
New agents for treating obesity disclosed in recent patent literature
Read More
Antiinfective agents emerge from pharma R&D
Read More
Novel therapeutics for cardiovascular diseases reported
Read More